Skip to main content
    S

    SRx Health Solutions Inc. (SRXH)

    Official site

    CONSUMER DEFENSIVE • MEDICAL CARE FACILITIES • AMEX

    $0.95
    -0.00 (-0.29%)

    Market Cap: $19.21M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    SRx Health Solutions Inc. (SRXH) Financials: Revenue, Profit and Cash Flow

    Updated Aug 13, 2026. Financial statements from company filings, amounts in US dollars.

    SRx Health Solutions reported revenue of $6.53M for the fiscal year ended Sep 30, 2025, down 87.0% from the year before. That year, net income was -$45.01M with a net margin of -688.8%, operating cash flow was -$8.14M and free cash flow was -$10.22M. The quarter ended Jun 30, 2026 had revenue of $3.39M and net income of -$4.14M.

    Revenue and Margins

    Over the 8 years to Sep 2025, revenue grew from $2.16K, a compound annual rate of 172.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$6.53M-87.0%23.4%-174.6%-688.8%
    Sep 2024$50.30M-68.9%36.8%-17.1%-0.5%
    Sep 2023$161.55M+74.4%19.9%-4.9%-9.4%
    Sep 2022$92.63M+58.0%14.4%-1.3%-2.6%
    Sep 2021$58.63M+7.8%29.8%-37.6%6.5%
    Sep 2020$54.38MN/A33.7%-64.2%-139.3%
    Sep 2018N/AN/AN/AN/AN/A
    Sep 2017$2.16KN/A80.7%-30226.1%-100549.7%
    Sep 2016N/AN/AN/AN/AN/A
    Sep 2015N/AN/AN/AN/AN/A
    Annual, fiscal years ended Sep 2015 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2018Sep 2017Sep 2016Sep 2015
    Revenue$6.53M$50.30M$161.55M$92.63M$58.63M$54.38MN/A$2.16KN/AN/A
    Cost of revenue$5.01M$31.80M$129.48M$79.33M$41.17M$36.06MN/AN/A$2.86K$2.90K
    Gross profit$1.53M$18.49M$32.07M$13.31M$17.47M$18.32MN/A$1.75K-$2.80K-$2.90K
    Research and development$0$143.81K$132.55K$671.82K$0$0$0$0$0$0
    Operating income-$11.41M-$8.58M-$7.89M-$1.17M-$22.02M-$34.89M-$685.70K-$654.09K-$275.03K-$32.60K
    Net income-$45.01M-$241.60K-$15.13M-$2.45M$3.80M-$75.76M-$14.27M-$2.18M-$1.22M-$65.69K
    EBITDA-$7.98M$6.40MN/A$1.01M$10.58MN/A-$685.70K-$654.09KN/A-$29.71K
    Fiscal years ended Sep 2015 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Sep 2023Jun 2023
    Revenue$3.39M$3.44M$2.81M-$47.05M$11.45M$7.16M$34.98M$15.36M$42.67M$7.90M$17.76M$13.96M
    Gross profit$904.00K$1.35M$1.05M-$15.46M$1.62M$2.38M$12.99M$6.06M$9.42M$2.61M$5.44M$4.20M
    Operating income-$3.20M-$1.82M-$3.79M$10.38M-$14.73M-$1.09M-$5.97M-$1.52M-$1.32M-$2.47M-$3.54M-$3.42M
    Net income-$4.14M-$6.38M-$8.61M-$21.28M-$15.13M-$964.00K-$168.00K$2.06M-$3.12M-$2.83M-$2.20M-$3.93M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, total debt of $4.47M exceeded cash and equivalents by $3.16M.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2018Sep 2017Sep 2016Sep 2015
    Total assets$8.40M$22.72M$42.05M$34.79M$98.67M$65.44M$271.58K$27.08K$28.73KN/A
    Current assets$8.13M$21.57M$25.13M$14.80M$55.97M$22.43M$271.58K$20.38K$21.72KN/A
    Cash and equivalents$1.31M$4.74M$2.07M$1.66M$36.89M$5.09M$259.37K$1.80K$13.31KN/A
    Total liabilities$8.00M$120.62M$70.80M$33.86M$24.91M$101.33M$3.71M$1.50M$771.29KN/A
    Short-term debt$21.00K$52.91M$35.81M$6.56M$1.16M$10.46M$353.22K$788.53K$348.82KN/A
    Long-term debt$4.45M$696.00KN/AN/AN/AN/AN/AN/AN/AN/A
    Shareholder equity$407.00K$13.91M$15.08M$62.20M$73.76M-$35.88M-$3.44M-$1.47MN/AN/A
    Fiscal years ended Sep 2015 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Sep 2023Jun 2023
    Total assets$145.36M$43.36M$27.05M$11.72M$33.98M$10.63M$22.72M$23.20M$17.90M$20.96M$42.05M$40.28M
    Total liabilities$2.37M$25.08M$23.53M$11.15M$79.86M$5.09M$10.29M$9.28M$12.51M$19.43M$21.63M$18.78M
    Cash and equivalents$36.69M$20.54M$13.06M$1.83M$912.00K$790.21K$4.41M$6.41M$4.50M$5.26M$5.15M$4.78M
    Shareholder equity$142.99M$18.29M$3.52M$567.65K-$45.88M$5.53M$12.44M$13.91M$5.39M$1.53M$20.42M$21.49M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Sep 2025.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2018Sep 2017Sep 2016
    Operating cash flow-$8.14MN/A$97.00K-$20.55M-$15.11MN/A-$1.04M-$49.62KN/A
    Capital expenditures$2.08MN/A$18.00K$198.00K$449.89K$192.81K$0N/A$235.71K
    Free cash flow-$10.22MN/A$79.00K-$20.75M-$15.56MN/A-$1.04MN/AN/A
    Investing cash flow$5.91MN/A-$18.00K-$198.00K-$449.89K-$192.81KN/AN/A-$326.29K
    Financing cash flow$12.17M$7.08M-$5.10M$1.28M$47.36M$11.74M$1.30M$38.69K$575.31K
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Sep 2023Jun 2023
    Operating cash flow-$956.00K-$3.62M-$2.92M$7.60M-$16.13M$384.00K-$1.68M-$2.98M$27.35K-$1.01M$464.50K$312.64K
    Capital expenditures$0$0$8.46M$0$7.00K$7.00K$17.26K$14.86K$20.51K$3.00K$0$0
    Free cash flow-$956.00K-$3.62M-$11.38M$7.60M-$16.14M$377.00K-$1.70M-$2.99M$6.84K-$1.01M$464.50K$312.64K
    Last 12 quarters

    Frequently Asked Questions About SRXH

    What is SRx Health Solutions' annual revenue?

    SRx Health Solutions reported revenue of $6.53M for the fiscal year ended Sep 30, 2025.

    How fast is SRx Health Solutions' revenue growing?

    Revenue was down 87.0% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -58.7%.

    Is SRx Health Solutions profitable?

    No. SRx Health Solutions reported net income of -$45.01M for the fiscal year ended Sep 30, 2025, with a net margin of -688.8%.

    How much free cash flow does SRXH generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of -$8.14M minus capital expenditures of $2.08M produced free cash flow of -$10.22M.

    How much debt does SRx Health Solutions have?

    The balance sheet dated Sep 30, 2025 reported long-term debt of $4.45M, short-term debt of $21.00K and cash and equivalents of $1.31M.